Last reviewed · How we verify
GTA glyceryl triacetate
At a glance
| Generic name | GTA glyceryl triacetate |
|---|---|
| Sponsor | Shaare Zedek Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Lithium and Acetate for Canavan Disease (PHASE2)
- Oral Glyceryl Triacetate (GTA) in Newborns With Canavan (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GTA glyceryl triacetate CI brief — competitive landscape report
- GTA glyceryl triacetate updates RSS · CI watch RSS
- Shaare Zedek Medical Center portfolio CI